论文部分内容阅读
目的 :比较复方丹参加西沙必利及单用西沙必利治疗老年功能性便秘的疗效。方法 :5 4例临床诊断老年功能性便秘病人 ,随机分为治疗组 2 7例(男性 18例 ,女性 9例 ,年龄 65a±s 12a) ,餐前服复方丹参片 3片 ,tid ,加西沙必利 5mg ,tid ;对照组2 7例 ,单用西沙必利 5mg ,tid ;疗程均为 3mo。结果 :治疗 1,2mo后 ,2组便秘缓解率分别为 37% ,5 6%和 37% ,5 2 % (P >0 .0 5 ) ,3mo后分别为 93%和 78% (P >0 .0 5 )。随访 6mo ,2组便秘复发率分别为 8%和 2 9% (P >0 .0 5 )。结论 :单用西沙必利与复方丹参加西沙必利疗效无差异
Objective: To compare the efficacy of compound salvia miltiorrhiza plus cisapride and cisapride alone in the treatment of senile functional constipation. Methods: 54 cases of senile patients with functional constipation were randomly divided into treatment group 27 cases (18 males and 9 females, age 65a ± s 12a), 3 tablets of Danshen tablets before meals, tid, Palliative 5mg, tid; control group 27 cases, with cisapride 5mg, tid; course of treatment were 3mo. Results: The remission rate of constipation was 37%, 56% and 37%, 52% (P> 0.05) in the two groups after treatment for 1 and 2 months, respectively, 93% and 78% after 3 months .0 5). Follow-up 6mo, 2 groups of constipation recurrence rates were 8% and 29% (P> 0.05). Conclusion: There is no difference between cisapride alone and compound salvia miltiorrhiza plus cisapride